0001209191-23-047246.txt : 20230824 0001209191-23-047246.hdr.sgml : 20230824 20230824184929 ACCESSION NUMBER: 0001209191-23-047246 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220729 FILED AS OF DATE: 20230824 DATE AS OF CHANGE: 20230824 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dupont Jakob CENTRAL INDEX KEY: 0001553335 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39488 FILM NUMBER: 231203370 MAIL ADDRESS: STREET 1: C/O ONCOMED PHARMACEUTICALS, INC. STREET 2: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apexigen, Inc. CENTRAL INDEX KEY: 0001814140 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851260244 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 INDUSTRIAL ROAD, SUITE C CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650.931.6236 MAIL ADDRESS: STREET 1: 900 INDUSTRIAL ROAD, SUITE C CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: Brookline Capital Acquisition Corp. DATE OF NAME CHANGE: 20200603 3/A 1 doc3a.xml FORM 3/A SUBMISSION X0206 3/A 2022-07-29 2022-08-08 0 0001814140 Apexigen, Inc. APGN 0001553335 Dupont Jakob C/O APEXIGEN, INC. 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070 1 0 0 0 Stock Option (right to buy) 4.49 2031-02-12 Common Stock 20489 D Prior to the date on which the reporting person became subject to Section 16, he was granted an option to purchase 20,489 shares of common stock which vest upon the satisfaction of certain performance metrics. The first threshold was met resulting in the vesting of 5,122 shares. The remaining shares vest upon the achievement of certain additional performance metrics or upon a change in control. This amendment on Form 3 is filed to report an option that was inadvertently omitted from the Form 3 filed on August 8, 2022. /s/ Francis Sarena, by power of attorney 2023-08-24